
No Stock Yet
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersZyVersa Therapeutics (NASDAQ:ZVSA) shares increased by 31.4% to $2.14 during Thursday's regular session. As of 13:30 EST, this security is trading at a volume of 8.9 million shares, making up 2
Stocks That Hit 52-Week Lows On Thursday
 On Thursday, 175 stocks hit new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: Johnson & Johnson (NYSE:JNJ) was the largest firm by market cap to set a new 52-week low.The smallest
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersThe Oncology Institute (NASDAQ:TOI) stock moved upwards by 27.6% to $0.86 during Wednesday's regular session. Trading volume for this security as of 13:30 EST is 319.9K, which is 202.1% of its
Marker Therapeutics Shares Are Trading Lower After the Company Reported FY22 Financial Results.
Marker Therapeutics shares are trading lower after the company reported FY22 financial results.
Marker Therapeutics GAAP EPS of -$3.58 Beats by $0.02, Revenue of $9.01M Beats by $0.01M
Marker Therapeutics Reports FY22 Corporate and Financial Results; At December 31, 2022, Marker Had Cash And Cash Equivalents Of $11.8M
Cash Position and Guidance: At December 31, 2022, Marker had cash and cash equivalents of $11.8 million. The Company believes that its existing cash, cash equivalents and restricted cash will fund its operating expenses and capital expenditure requirements into the third quarter of 2023.
Marker Therapeutics Sees Funding Into 3Q >MRKR
Marker Therapeutics Sees Funding Into 3Q >MRKR
Press Release: Marker Therapeutics Reports Fiscal Year 2022 Corporate and Financial Results
Marker Therapeutics Reports Fiscal Year 2022 Corporate and Financial Results 2022 CLINICAL AND REGULATORY HIGHLIGHTS -- Awarded $2 million grant from U.S. Food and Drug Administration (FDA) for
Marker Therapeutics FY22 Loss/Shr $3.58 >MRKR
Marker Therapeutics FY22 Loss/Shr $3.58 >MRKR
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersVirax Biolabs Group (NASDAQ:VRAX) shares increased by 129.3% to $1.52 during Tuesday's pre-market session. The company's market cap stands at $19.4 million. Adial Pharmaceuticals (NASDAQ:ADIL)
Loading...
No Stock Yet